On ECHEMI
Home > Drugs > Jiangsu Jibeier Pharmaceutical Co., Ltd.

Jiangsu Jibeier Pharmaceutical Co., Ltd.

  • Founded in:

    2001-11-13
  • Country:

    China China
  • Address:

    Zhenjiang High-tech Industrial Development Park
  • Tax NO.:

    913211007317784571
  • Registered Funds:

    199.430865 yuan
  • Website:

  • Email:

Related Drugs
Menadione Acetate Tablets
2-Methyl-1,4-naphthalene diol diacetate
Name Description Content CAS NO. Registered Holders
Menadiol diacetate

Vitamin K is a substance necessary for the liver to synthesize coagulation factors II, VII, IX and X. Vitamin K deficiency can cause synthesis disorders of these coagulation factors, and clinically, bleeding tendency and prolonged prothrombin time can be seen. Natural vitamin K includes K1 and K2, which are fat-soluble and their absorption depends on the normal secretion of bile. Artificially synthesized vitamin K includes K3 and K4, the former is sodium bisulfite menadione, and the latter is acetyl menadione, which are water-soluble and do not require the presence of bile for their absorption.

More

Vitamin K is a substance necessary for the liver to synthesize coagulation factors II, VII, IX and X. Vitamin K deficiency can cause synthesis disorders of these coagulation factors, and clinically, bleeding tendency and prolonged prothrombin time can be seen. Natural vitamin K includes K1 and K2, which are fat-soluble and their absorption depends on the normal secretion of bile. Artificially synthesized vitamin K includes K3 and K4, the former is sodium bisulfite menadione, and the latter is acetyl menadione, which are water-soluble and do not require the presence of bile for their absorption.

573-20-6 3
Metronidazole
The main ingredient is metronidazole, and its chemical name is 2-methyl-5-nitroimidazole-1-target=_blank ethanol.
Name Description Content CAS NO. Registered Holders
Metronidazole

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on Amoeba histolytica. When the concentration is 1-2μg/ml, the morphological changes can occur in 6-20 hours, and all are killed within 24 hours; when the concentration is 0.2g/ml, Amoeba histolytica can be killed within 72 hours. It has a strong killing effect on Trichomonas, and the antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Bacillus aerogenes, Eubacterium, Peptococcus and Peptostreptococcus. It has a killing effect on cells and anaerobic microorganisms growing under hypoxic conditions. The metabolites generated during reduction in the human body also have anti-anaerobic effects, inhibiting bacterial growth and reproduction by interfering with the bacterial DNA metabolism process, and ultimately leading to cell death.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. It has a strong killing effect on Amoeba histolytica. When the concentration is 1-2μg/ml, the morphological changes can occur in 6-20 hours, and all are killed within 24 hours; when the concentration is 0.2g/ml, Amoeba histolytica can be killed within 72 hours. It has a strong killing effect on Trichomonas, and the antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Bacillus aerogenes, Eubacterium, Peptococcus and Peptostreptococcus. It has a killing effect on cells and anaerobic microorganisms growing under hypoxic conditions. The metabolites generated during reduction in the human body also have anti-anaerobic effects, inhibiting bacterial growth and reproduction by interfering with the bacterial DNA metabolism process, and ultimately leading to cell death.

443-48-1 39
Aceclofenac
Name Description Content CAS NO. Registered Holders
Aceclofenac

Extract from the above information

More

Extract from the above information

89796-99-6 14
Gatifloxacin eye drops
The main ingredient of this product is gatifloxacin. Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid Molecular weight: C19H22FN3O4
Name Description Content CAS NO. Registered Holders
Gatifloxacin

DNA gyrase inhibitors are also topoisomerase IV inhibitors. They exert their bactericidal effects by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. They are essential in DNA replication, transcription, repair, recombination, and conversion and translocation.

More

DNA gyrase inhibitors are also topoisomerase IV inhibitors. They exert their bactericidal effects by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. They are essential in DNA replication, transcription, repair, recombination, and conversion and translocation.

112811-59-3 20
Neomycin Sulfate Tablets
Neomycin Sulfate
Name Description Content CAS NO. Registered Holders
Neomycin sulfate

Neomycin sulfate is an aminoglycoside antibiotic. This product has good antibacterial effect on Enterobacteriaceae such as Staphylococcus (methicillin-sensitive strains), Corynebacterium, Escherichia coli, Klebsiella, Proteus, etc., and has poor activity against various groups of Streptococci, Streptococcus pneumoniae, Enterococcus, etc. Pseudomonas aeruginosa and anaerobic bacteria are resistant to this product. Bacteria have partial or complete cross-resistance to streptomycin, neomycin, kanamycin, and gentamicin. Systemic neomycin has significant nephrotoxicity and ototoxicity, so it is currently limited to oral or topical application.

More

Neomycin sulfate is an aminoglycoside antibiotic. This product has good antibacterial effect on Enterobacteriaceae such as Staphylococcus (methicillin-sensitive strains), Corynebacterium, Escherichia coli, Klebsiella, Proteus, etc., and has poor activity against various groups of Streptococci, Streptococcus pneumoniae, Enterococcus, etc. Pseudomonas aeruginosa and anaerobic bacteria are resistant to this product. Bacteria have partial or complete cross-resistance to streptomycin, neomycin, kanamycin, and gentamicin. Systemic neomycin has significant nephrotoxicity and ototoxicity, so it is currently limited to oral or topical application.

1405-10-3 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.